mounjaro is glp 1 GLP-1 use tripled among non-diabetics, reaching $5.8B in 2022 Mounjaro (Tirzepatide) GLP-1 injection -
Description
Our preclinical findings highlight its potential therapeutic use for patients seeking improved glycemic control without the loss of appetite and emesis characteristic of current GLP-1 therapeutics
Agency, Ozempic, INN-semaglutide - Accessed June 2018
This article is general education and not medical advice
Most fatigue during GLP-1 therapy stems from reduced calorie intake or rapid weight loss rather than the medication directly
Ginger chews can help between meals
The mean duration of type 2 diabetes mellitus was 7.6 years and the mean BMI was 33 kg/m2
